AV nodal ablation: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 24: Line 24:
With the advent of AVNA, some complications have been reported including the development of [[inappropriate sinus tachycardia]]<ref name="Kocovic-1993">{{Cite journal  | last1 = Kocovic | first1 = DZ. | last2 = Harada | first2 = T. | last3 = Shea | first3 = JB. | last4 = Soroff | first4 = D. | last5 = Friedman | first5 = PL. | title = Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Delineation of parasympathetic pathways in the human heart. | journal = Circulation | volume = 88 | issue = 4 Pt 1 | pages = 1671-81 | month = Oct | year = 1993 | doi =  | PMID = 8403312 }}</ref> which occurs when radiofrequency ablation in the anterior, mid, and posterior regions of the low interatrial septum disrupts the parasympathetic fibers destined to innervate the sinus node.  Some episodes of [[ventricular fibrillation]]<ref name="Geelen-1997">{{Cite journal  | last1 = Geelen | first1 = P. | last2 = Brugada | first2 = J. | last3 = Andries | first3 = E. | last4 = Brugada | first4 = P. | title = Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. | journal = Pacing Clin Electrophysiol | volume = 20 | issue = 2 Pt 1 | pages = 343-8 | month = Feb | year = 1997 | doi =  | PMID = 9058872 }}</ref> have also been reported.  Also, a very rare case of an acquired ventriculo-atrial shunt (between the [[left ventricle]] and the [[right atrium]] (Gerbode defect) was reported.<ref name="Sharma-2011">{{Cite journal  | last1 = Sharma | first1 = AK. | last2 = Chander | first2 = R. | last3 = Singh | first3 = JP. | title = AV nodal ablation-induced Gerbode defect (LV-RA Shunt). | journal = J Cardiovasc Electrophysiol | volume = 22 | issue = 11 | pages = 1288-9 | month = Nov | year = 2011 | doi = 10.1111/j.1540-8167.2011.02111.x | PMID = 21649778 }}</ref>  Some patients with AVNA and right ventricular pacing (pacemaker situated in the right ventricle) experience interventricular dyssynchrony which involves right ventricle contracting before the left ventricle.  This condition, which causes a reduction in left ventricular output or result in mortality, may require [[cardiac resynchronization therapy]] (CRT).
With the advent of AVNA, some complications have been reported including the development of [[inappropriate sinus tachycardia]]<ref name="Kocovic-1993">{{Cite journal  | last1 = Kocovic | first1 = DZ. | last2 = Harada | first2 = T. | last3 = Shea | first3 = JB. | last4 = Soroff | first4 = D. | last5 = Friedman | first5 = PL. | title = Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Delineation of parasympathetic pathways in the human heart. | journal = Circulation | volume = 88 | issue = 4 Pt 1 | pages = 1671-81 | month = Oct | year = 1993 | doi =  | PMID = 8403312 }}</ref> which occurs when radiofrequency ablation in the anterior, mid, and posterior regions of the low interatrial septum disrupts the parasympathetic fibers destined to innervate the sinus node.  Some episodes of [[ventricular fibrillation]]<ref name="Geelen-1997">{{Cite journal  | last1 = Geelen | first1 = P. | last2 = Brugada | first2 = J. | last3 = Andries | first3 = E. | last4 = Brugada | first4 = P. | title = Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. | journal = Pacing Clin Electrophysiol | volume = 20 | issue = 2 Pt 1 | pages = 343-8 | month = Feb | year = 1997 | doi =  | PMID = 9058872 }}</ref> have also been reported.  Also, a very rare case of an acquired ventriculo-atrial shunt (between the [[left ventricle]] and the [[right atrium]] (Gerbode defect) was reported.<ref name="Sharma-2011">{{Cite journal  | last1 = Sharma | first1 = AK. | last2 = Chander | first2 = R. | last3 = Singh | first3 = JP. | title = AV nodal ablation-induced Gerbode defect (LV-RA Shunt). | journal = J Cardiovasc Electrophysiol | volume = 22 | issue = 11 | pages = 1288-9 | month = Nov | year = 2011 | doi = 10.1111/j.1540-8167.2011.02111.x | PMID = 21649778 }}</ref>  Some patients with AVNA and right ventricular pacing (pacemaker situated in the right ventricle) experience interventricular dyssynchrony which involves right ventricle contracting before the left ventricle.  This condition, which causes a reduction in left ventricular output or result in mortality, may require [[cardiac resynchronization therapy]] (CRT).


Despite all this, AVNA has been associated with a reduction in all-cause mortality and cardiovascular mortality in patients with coexisting atrial fibrillation and heart failure when compared with medical therapy.<ref name="Ganesan-2012">{{Cite journal  | last1 = Ganesan | first1 = AN. | last2 = Brooks | first2 = AG. | last3 = Roberts-Thomson | first3 = KC. | last4 = Lau | first4 = DH. | last5 = Kalman | first5 = JM. | last6 = Sanders | first6 = P. | title = Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. | journal = J Am Coll Cardiol | volume = 59 | issue = 8 | pages = 719-26 | month = Feb | year = 2012 | doi = 10.1016/j.jacc.2011.10.891 | PMID = 22340263 }}</ref>
Despite all this, AVNA has been associated with a reduction in all-cause mortality and cardiovascular mortality in patients with coexisting atrial fibrillation and heart failure when compared with medical therapy.<ref name="Ganesan-2012">{{Cite journal  | last1 = Ganesan | first1 = AN. | last2 = Brooks | first2 = AG. | last3 = Roberts-Thomson | first3 = KC. | last4 = Lau | first4 = DH. | last5 = Kalman | first5 = JM. | last6 = Sanders | first6 = P. | title = Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. | journal = J Am Coll Cardiol | volume = 59 | issue = 8 | pages = 719-26 | month = Feb | year = 2012 | doi = 10.1016/j.jacc.2011.10.891 | PMID = 22340263 }}</ref> Conversely in another study, AVNA with implantable permanent pacemakers had no significant effect on the long-term survival of patient with atrial fibrillation when compared with drug therapy.


==References==
==References==

Revision as of 23:23, 5 September 2013

WikiDoc Resources for AV nodal ablation

Articles

Most recent articles on AV nodal ablation

Most cited articles on AV nodal ablation

Review articles on AV nodal ablation

Articles on AV nodal ablation in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on AV nodal ablation

Images of AV nodal ablation

Photos of AV nodal ablation

Podcasts & MP3s on AV nodal ablation

Videos on AV nodal ablation

Evidence Based Medicine

Cochrane Collaboration on AV nodal ablation

Bandolier on AV nodal ablation

TRIP on AV nodal ablation

Clinical Trials

Ongoing Trials on AV nodal ablation at Clinical Trials.gov

Trial results on AV nodal ablation

Clinical Trials on AV nodal ablation at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on AV nodal ablation

NICE Guidance on AV nodal ablation

NHS PRODIGY Guidance

FDA on AV nodal ablation

CDC on AV nodal ablation

Books

Books on AV nodal ablation

News

AV nodal ablation in the news

Be alerted to news on AV nodal ablation

News trends on AV nodal ablation

Commentary

Blogs on AV nodal ablation

Definitions

Definitions of AV nodal ablation

Patient Resources / Community

Patient resources on AV nodal ablation

Discussion groups on AV nodal ablation

Patient Handouts on AV nodal ablation

Directions to Hospitals Treating AV nodal ablation

Risk calculators and risk factors for AV nodal ablation

Healthcare Provider Resources

Symptoms of AV nodal ablation

Causes & Risk Factors for AV nodal ablation

Diagnostic studies for AV nodal ablation

Treatment of AV nodal ablation

Continuing Medical Education (CME)

CME Programs on AV nodal ablation

International

AV nodal ablation en Espanol

AV nodal ablation en Francais

Business

AV nodal ablation in the Marketplace

Patents on AV nodal ablation

Experimental / Informatics

List of terms related to AV nodal ablation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Synonyms and keywords: AVNA

Overview

Atrioventricular nodal or AV junction ablation is a procedure by which the electrical pathways that connect the atria to the ventricles are modified or interrupted in order to restore a normal cardiac rhythm. This procedure creates a disconnect between the upper chambers (which controls the heart rate and rhythm) and the lower chambers (ventricles). Due to the invasive nature of the procedure and the requirement for a pacemaker implantation, AVNA is mostly as a fallback treatment in patients with atrial fibrillation that is refractory to medications, or have developed side effects to the medications. It is important to note that this procedure is not a cure for the atrial fibrillation, its function is to regulate the ventricular rate. Therefore, patients will still require life-long anticoagulation.

Indications

Procedure

Process

During this procedure, a special catheter is passed through the femoral vein into the heart under fluoroscopic guidance. Once the catheter is in place, a small amount of radiofrequency energy or heat is applied adjacent to the AV node in order to destroy it or create a scar which permanently blocks the entry of fast impulses from the atrium. After a successful ablation, the ventricles will no longer respond to the impulses from the atria, in other words, they beat independently of each other. The ventricular rate is about 40 beats per minute which may be too slow for adequate perfusion under exercise conditions, therefore, an implantation of a permanent pacemaker is required. The choice of pacemaker depends on the overall clinical status of the patient. This could be a single chamber versus a dual chamber ventricular pacemaker. A single chamber pacemaker may be adequate for a patient with chronic atrial fibrillation while a patient with paroxysmal AF may require a dual chamber pacemaker.

Risks of The Procedure

The procedure is relatively safe, but there are some risks associated with the procedure either during or after the procedure. They are:

  • Cardiac tamponade - This occurs in less than 1% of cases. The catheter electrode may perforate the heart causing a collection of blood around the heart. This may require the insertion of a drain to remove the blood.
  • Damage to the blood vessels - Occasionally, the blood vessels may be perforated by the catheter electrode.
  • Iatrogenic pneumothorax - The lung wall may be punctured resulting into leakage of air into the pleural space. This may require a drain in order to re-inflate the lungs.
  • Other risks include but not limited to hemorrhage at the operation site, hemothorax, pulmonary embolism, stroke, but these are extremely rare.

Complications and Prognosis

With the advent of AVNA, some complications have been reported including the development of inappropriate sinus tachycardia[1] which occurs when radiofrequency ablation in the anterior, mid, and posterior regions of the low interatrial septum disrupts the parasympathetic fibers destined to innervate the sinus node. Some episodes of ventricular fibrillation[2] have also been reported. Also, a very rare case of an acquired ventriculo-atrial shunt (between the left ventricle and the right atrium (Gerbode defect) was reported.[3] Some patients with AVNA and right ventricular pacing (pacemaker situated in the right ventricle) experience interventricular dyssynchrony which involves right ventricle contracting before the left ventricle. This condition, which causes a reduction in left ventricular output or result in mortality, may require cardiac resynchronization therapy (CRT).

Despite all this, AVNA has been associated with a reduction in all-cause mortality and cardiovascular mortality in patients with coexisting atrial fibrillation and heart failure when compared with medical therapy.[4] Conversely in another study, AVNA with implantable permanent pacemakers had no significant effect on the long-term survival of patient with atrial fibrillation when compared with drug therapy.

References

  1. Kocovic, DZ.; Harada, T.; Shea, JB.; Soroff, D.; Friedman, PL. (1993). "Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Delineation of parasympathetic pathways in the human heart". Circulation. 88 (4 Pt 1): 1671–81. PMID 8403312. Unknown parameter |month= ignored (help)
  2. Geelen, P.; Brugada, J.; Andries, E.; Brugada, P. (1997). "Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction". Pacing Clin Electrophysiol. 20 (2 Pt 1): 343–8. PMID 9058872. Unknown parameter |month= ignored (help)
  3. Sharma, AK.; Chander, R.; Singh, JP. (2011). "AV nodal ablation-induced Gerbode defect (LV-RA Shunt)". J Cardiovasc Electrophysiol. 22 (11): 1288–9. doi:10.1111/j.1540-8167.2011.02111.x. PMID 21649778. Unknown parameter |month= ignored (help)
  4. Ganesan, AN.; Brooks, AG.; Roberts-Thomson, KC.; Lau, DH.; Kalman, JM.; Sanders, P. (2012). "Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review". J Am Coll Cardiol. 59 (8): 719–26. doi:10.1016/j.jacc.2011.10.891. PMID 22340263. Unknown parameter |month= ignored (help)

Template:WH Template:WS